effect of interapitonial bupivacaine on postoperative pain

The effect of interapitonial bupivacaine on postoperative pain in laparoscopic bariatric surgery

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20140109016151N6

Enrollment

100

Registered

2018-09-22

Start date

2017-09-23

Completion date

Unknown

Last updated

2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid Obesity. Other obesity

Interventions

Intervention 1: Intervention group: 50 cc of 0.2% bupivacaine is prescibed. Intervention 2: Control group: 50 cc normal saline is prescibed.

Eligibility

Sex/Gender

All

Age

17 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients undergoing laparoscopic bariatric surgery with BMI>40 . With age 17-60 years. ASA 2.

Exclusion criteria

Exclusion criteria: Exclusion criteria: patients with history of analgesics (narcotic or non-narcotic) 24 hours before surgery. Drug or alcohol abuse or allergy to any of the drugs used in the study. Chronic pain syndrome.

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: 2, 8 and 24 hours after surgery. Method of measurement: based on a visual scale VAS.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Alireza Pournajafian

Iran University of Medical Sciences

a-pournajafian@tums.ac.ir+98 21 8894 6762

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026